Delivery Order SPE2DB20D3103-SPE2DB24FN2A0
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $8,357.70 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty pharmaceutical product. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,846.14 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $12,801.03 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Cyclosporine 0.05% eye emulsion. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,107.10 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Cyclosporine 0.05% eye emulsion medication. The contract has a potential value of $1,954.08 and a performance period through February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,233.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565664445 - Cyclosporine 0.05% eye emulsion. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military...
- This is a Delivery Order valued at $7,949.34 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a period of performance through June 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for CYCLOSPORINE 0.05% EYE EMULS 60S. The delivery order has a potential value of $7,335.36 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals and medical supplies to U.S. government agencies, particularly the Department of Defense. The contract does...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2A0Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,432.00 contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to provide a comprehensive range of medications and healthcare materials to DLA Troop Support Medical locations worldwide. No set-aside designation was used for this specific delivery order. The contract has an ultimate completion date of March 28, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/27/24 |